Long-Term Outcomes of Surgical Aortic Valve Replacement Utilizing a Third Generation Stented Bovine Pericardial Bioprosthesis in 1907 Patients

Key Points

• This research aims to evaluate the long-term outcomes of surgical aortic valve replacement using a third-generation bovine pericardial bioprosthesis.
• Analysis conducted on 1907 patients undergoing surgical aortic valve replacement
• Long-term follow-up to assess morbidity and mortality rates
• Utilization of a third-generation stented bioprosthesis
• Mortality rate observed at 5 years was 15% (95% CI, 12%-18%), p=0.001
• Morbidity related to valve dysfunction was 8% at 10 years
• Improved hemodynamic performance compared to previous generations of bioprostheses